
ILMN
Healthcare · Diagnostics & Research · $31.30B market cap
$207.01-2.54 (-1.2%)Nov 13, 4:15 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -0.4% over 90 days · 30-day revisions 6 up, 7 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 29, 2026 | After the close | 1.36 | 1.44 | +5.9% |
| Jul 30, 2026 | After the close | 1.23 | 1.31 | +6.5% |
| Apr 30, 2026 | After the close | 1.06 | 1.15 | +8.5% |
| Feb 5, 2026 | After the close | 1.23 | 1.35 | +9.8% |
| Oct 30, 2025 | After the close | 1.17 | 1.34 | +14.5% |
| Jul 31, 2025 | After the close | 1.01 | 1.19 | +17.8% |
| May 8, 2025 | After the close | 0.94 | 0.97 | +3.2% |
| Feb 6, 2025 | After the close | 0.92 | 0.86 | -6.5% |
| Nov 4, 2024 | After the close | 0.88 | 1.14 | +29.5% |
| Aug 6, 2024 | After the close | 0.90 | 0.36 | -60.0% |
| May 2, 2024 | After the close | 0.11 | 0.09 | -18.2% |
| Feb 8, 2024 | After the close | 0.12 | 0.14 | +16.7% |
| Nov 9, 2023 | After the close | 0.14 | 0.33 | +135.7% |
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and…
| Aug 9, 2023 | After the close | 0.02 | 0.32 | +1500.0% |
| Apr 25, 2023 | After the close | 0.03 | 0.08 | +166.7% |
| Feb 7, 2023 | After the close | 0.19 | 0.14 | -26.3% |
| Nov 3, 2022 | After the close | 0.30 | 0.34 | +13.3% |
| Aug 11, 2022 | After the close | 0.64 | 0.57 | -10.9% |
| May 5, 2022 | After the close | 0.89 | 1.07 | +20.2% |
| Feb 10, 2022 | After the close | 0.49 | 0.75 | +53.1% |
| Nov 4, 2021 | After the close | 1.22 | 1.45 | +18.9% |
| Aug 5, 2021 | After the close | 1.36 | 1.87 | +37.5% |
| Apr 27, 2021 | After the close | 1.40 | 1.89 | +35.0% |
| Feb 11, 2021 | After the close | 1.11 | 1.22 | +9.9% |
| Oct 29, 2020 | After the close | 0.80 | 1.02 | +27.5% |
| Aug 6, 2020 | After the close | 0.67 | 0.62 | -7.5% |
| Apr 30, 2020 | After the close | 1.25 | 1.64 | +31.2% |
| Jan 29, 2020 | After the close | 1.58 | 1.70 | +7.6% |
| Oct 24, 2019 | After the close | 1.41 | 1.93 | +36.9% |
| Jul 29, 2019 | After the close | 1.34 | 1.35 | +0.7% |
| Apr 25, 2019 | After the close | 1.35 | 1.60 | +18.5% |
| Jan 29, 2019 | After the close | 1.36 | 1.32 | -2.9% |
| Oct 23, 2018 | After the close | 1.26 | 1.52 | +20.6% |
| Jul 30, 2018 | After the close | 1.11 | 1.43 | +28.8% |
| Apr 24, 2018 | After the close | 1.02 | 1.45 | +42.2% |
| Jan 30, 2018 | After the close | 1.21 | 1.44 | +19.0% |